Acute Pancreatitis: Biology, Diagnosis and Therapy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 207
Special Issue Editor
2. Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Biosciences Building, Crown Street, Liverpool L69 7BE, UK
Interests: inflammation; cell signaling; cell death; molecular cell biology; biomarker discovery; translational drug discovery
Special Issue Information
Dear Colleagues,
Acute pancreatitis has potentially devastating consequences and no targeted drug therapy at present. The disease has rising incidence rates worldwide and severe forms of the disease carry a significant burden of morbidity and mortality. Through sustained research endeavors, multiple critical pathogenic mechanisms have been identified that play a role in disease pathogenesis; however, none have been translated to positive clinical trial results yet. This Special Issue focuses on the latest developments in acute pancreatitis, including the identification of the most promising novel pathogenic mechanisms and putative drug targets, biomarker discovery, and the assessment of unique diagnostic and prognostic tests, alongside the evaluation of original therapeutic approaches in preclinical settings. The Special Issue aims to emphasize key areas of therapeutic promise and highlight discoveries likely to be of significant future benefit in the treatment of disease.
Dr. Rajarshi Mukherjee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreatitis
- pathophysiology
- inflammation
- diagnostics
- biomarkers
- drug discovery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.